Marta Borges‐Canha

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the <scp>FIGHT</scp> trial

João Sérgio Neves, Francisco Vasques‐Nóvoa, Marta Borges‐Canha et al. · Diabetes Obesity and Metabolism · 2022 · 75 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +16

Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review

Madalena von Hafe, Marta Borges‐Canha, Catarina Vale et al. · Metabolites · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pathology +12

PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle‐Aged Population: The STANISLAS Cohort

João Pedro Ferreira, Constance Xhaard, Zohra Lamiral et al. · Journal of the American Heart Association · 2020 · 28 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity

Marta Borges‐Canha, João Sérgio Neves, Fernando Mendonça et al. · Frontiers in Endocrinology · 2020 · 28 citations · Full text

Medicine, Endocrinology, Clinical Nutrition +16

Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes

João Pedro Ferreira, Abhinav Sharma, Francisco Vasques‐Nóvoa et al. · European Journal of Heart Failure · 2022 · 28 citations

Medicine, Cardiology, Pharmacology +15